Zurich, 21 May 2025
Important information
The information contained in this document has not been verified by an independent source. It should be taken with caution, and no assurance or guarantee is given (either explicit or implied) regarding the fairness, accuracy, completeness or correctness of the information or opinions contained herein. Neither Ypsomed Holding AG nor advisors or affiliates of Ypsomed Holding AG shall be liable in any way for losses occurred in conjunction with the use of this document, its contents or any other connection with this document. This document is neither an offer (or part of an offer) for the sale, nor a solicitation for the purchase of shares, and neither the document nor parts thereof form the basis of any contract or otherwise obligation. This document contains future-oriented statements which include uncertainties and risks. Such statements are indicated by such words as "could", "planned", "expected", "believed" and similar expressions or their context. These statements are made based on current knowledge and current assumptions. Due to a variety of different factors, the actual future results, developments or events may deviate considerably from those mentioned here. There is no obligation whatsoever to update future-oriented statements.
Making selfcare simpler and easier
Our growth drivers provide exciting opportunities
Selfcare
Enhancing quality of life, encouraging therapy adherence and facilitating more efficient healthcare systems
Biologics
Most new generation drugs with complex active pharmaceutical
ingredients must be injected
Biosimilars
Expanding global access to affordable medical care
GLP-1s
Transforming healthcare and society, improving public health, productivity, and quality of life for millions